{"action":"create","ckan_id":null,"date_created":"Wed, 03 Sep 2025 21:00:48 GMT","date_finished":null,"harvest_job_id":"22b5b228-5c22-478f-beac-c2ad93490783","harvest_source_id":"8e0c0837-e26e-432c-bb3b-dd0df4f1b9af","id":"0fd15f1e-d8dd-47ce-bac8-dc6fdfa88500","identifier":"https://data.cdc.gov/api/views/xfk2-6xmb","parent_identifier":null,"source_hash":"a008a846422fbb491d574378cc08854e356633792787a78cf675241c0eeb6ad7","source_raw":"{\"@type\": \"dcat:Dataset\", \"accessLevel\": \"public\", \"bureauCode\": [\"009:20\"], \"contactPoint\": {\"@type\": \"vcard:Contact\", \"fn\": \"Allergy and Clinical Immunology Branch (ACIB), Health Effects Laboratory Division (HELD)\", \"hasEmail\": \"mailto:sa-cin-webteam@cdc.gov\"}, \"description\": \"Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic man-made surfactants of over 12,000 compounds that are incorporated into numerous products for their chemical and physical properties.  Numerous PFAS have been associated with adverse health effects.  Although there is a high potential for dermal exposure, these studies are lacking.  The present study evaluated the systemic and immunotoxicity of sub-chronic 28- or 10-day dermal exposure, respectively, to of PFHpS (0.3125-2.5% or 7.82-62.5 mg/kg/dose) or PFOS (0.5% or 12.5 mg/kg/dose) in a murine model.\", \"distribution\": [{\"@type\": \"dcat:Distribution\", \"downloadURL\": \"https://data.cdc.gov/download/xfk2-6xmb/application/x-zip-compressed\", \"mediaType\": \"application/x-zip-compressed\"}], \"identifier\": \"https://data.cdc.gov/api/views/xfk2-6xmb\", \"issued\": \"2024-11-15\", \"landingPage\": \"https://data.cdc.gov/d/xfk2-6xmb\", \"license\": \"http://opendefinition.org/licenses/odc-odbl/\", \"modified\": \"2024-11-20\", \"programCode\": [\"009:034\"], \"publisher\": {\"@type\": \"org:Organization\", \"name\": \"Centers for Disease Control and Prevention\"}, \"theme\": [\"National Institute for Occupational Safety and Health\"], \"title\": \"Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model\"}","source_transform":null,"status":"error"}
